FIELD: medicine; immunology. SUBSTANCE: researchers determined percentage of promonocytes and mature monocytes contained in blood of patients suffering from viral hepatitis prior to administration of pyrogenal and two hours after administering such. When percent increment of above said cells was equal to 16 and above, pyrogenalotherapy was considered to be indicative and researchers could judge individual sensitivity of patients to pyrogenalotherapy. EFFECT: simplicity and less time required for investigation and increased specificity of disclosed method.
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR TREATMENT OF PATIENTS AFFECTED BY VIRAL HEPATITIS | 0 |
|
SU1685472A1 |
| METHOD OF DIFFERENTIAL DIAGNOSTICS OF VIRUS HEPATITIS AND MECHANICAL JAUNDICE | 0 |
|
SU944546A1 |
| METHOD OF DETERMINING PERSONAL SENSITIVITY OF ORGANISM TO PYROGENAL | 0 |
|
SU1404950A1 |
| METHOD OF PROPHYLAXIS OF POSTOPERATIVE COMPLICATIONS OF SUTURED WOUNDS | 1991 |
|
RU2067463C1 |
| METHOD FOR TREATMENT OF ACUTE HEPATITIS A INFECTION | 1990 |
|
RU2008007C1 |
| METHOD OF DETERMINING PATIENT'S SENSITIVITY TO PYROGENAL | 0 |
|
SU971271A1 |
| METHOD FOR DETERMINING AVERAGE RATE OF FORMATION OF HEPATIC FIBROSIS IN PATIENTS WITH CHRONIC HEPATITIS C | 2020 |
|
RU2739687C1 |
| METHOD OF TREATMENT PATIENTS FOR VIRUS HEPATITIS | 0 |
|
SU1806777A1 |
| METHOD OF DETERMINING THE AVERAGE RATE OF LIVER FIBROSIS FORMATION IN PATIENTS WITH CHRONIC HEPATITIS B+C | 2022 |
|
RU2801262C1 |
| METHOD OF ESTIMATING DEGREE OF COMMUNITY-ACQUIRED PNEUMONIA SEVERITY | 2013 |
|
RU2536951C1 |
